GSK posts COPD win for Nucala as Sanofi-Regeneron rival Dupixent nears delayed FDA decision
6th September 2024 Uncategorised 0GSK posts COPD win for Nucala as Sanofi-Regeneron rival Dupixent nears delayed FDA decision fkansteiner Fri, 09/06/2024 – 09:29 More: GSK posts COPD win for Nucala as Sanofi-Regeneron rival Dupixent nears delayed FDA decision Source: fierce
read more